WuXi Biologics (Cayman)

(OTC) WXIBF

Current Price$4.40

Market Cap$18.22B

Since IPO (2018)-36%

5 Year-73%

1 Year+37%

1 Month+2%

WuXi Biologics (Cayman) Financials at a Glance

Market Cap

$18.22B

Revenue (TTM)

CN¥40.27B

Net Income (TTM)

CN¥8.22B

EPS (TTM)

$0.16

P/E Ratio

26.30

Dividend

$0.00

Beta (Volatility)

0.42 (Low)

Dividend

$0.00

Beta (Volatility)

0.42 (Low)

Price

$4.40

Volume

15,621

Open

$4.40

Price

$4.40

Volume

15,621

Open

$4.40

Previous Close

$4.40

Daily Range

$4.40 - $4.40

52-Week Range

$2.85 - $5.61

Estimated Earnings Date

Aug 26, 2026

Dividend

$0.00

Beta (Volatility)

0.42 (Low)

Price

$4.40

Volume

15,621

Open

$4.40

Previous Close

$4.40

Daily Range

$4.40 - $4.40

52-Week Range

$2.85 - $5.61

Estimated Earnings Date

Aug 26, 2026

WXIBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi Biologics (Cayman)

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,252

CEO

Zhi Sheng Chen, PhD

Website

www.wuxibiologics.com

Headquarters

Wuxi, 214092, CN

WXIBF Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

30%

Net Income Margin

23%

Return on Equity

11%

Return on Capital

12%

Return on Assets

Earnings Yield

3.80%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.22B

Shares Outstanding

4.14B

Volume

15.62K

Avg. Volume

1.01K

Financials (TTM)

Gross Profit

CN¥9.76B

Operating Income

CN¥6.47B

EBITDA

CN¥8.17B

Operating Cash Flow

CN¥6.39B

Capital Expenditure

-CN¥3.59B

Free Cash Flow

CN¥2.80B

Cash & ST Invst.

CN¥15.75B

Total Debt

CN¥3.11B

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CN¥11.64B

+36.3%

Gross Profit

CN¥5.67B

+73.5%

Gross Margin

48.71%

N/A

Market Cap

$18.22B

N/A

Market Cap/Employee

$1.45M

N/A

Employees

12,575

N/A

Net Income

CN¥2.53B

+123.0%

EBITDA

CN¥4.73B

+122.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CN¥15.75B

+40.0%

Total Debt

CN¥3.11B

-31.9%

Accounts Receivable

CN¥8.90B

+43.9%

Inventory

CN¥1.44B

-18.4%

Long Term Debt

CN¥1.85B

-51.7%

Short Term Debt

CN¥1.26B

+71.8%

Return on Assets

7.70%

N/A

Return on Invested Capital

11.98%

N/A

Free Cash Flow

CN¥2.79B

+1176.6%

Operating Cash Flow

CN¥4.60B

+97.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SAUHYStraumann Holding AG

SAUHYStraumann Holding AG$11.69-1.06%

SAUHFStraumann Holding AG

SAUHFStraumann Holding AG$121.77+3.86%

IVBXFInnovent Biologics, Inc.

IVBXFInnovent Biologics, Inc.$9.79+2.02%

GNMSFGenmab A/S

GNMSFGenmab A/S$249.00+0.00%

ORINYOrion Oyj

ORINYOrion Oyj$39.00+2.67%

ALPMYAstellas Pharma Inc.

ALPMYAstellas Pharma Inc.$13.42+1.21%

SBMFFSino Biopharmaceutical Limited

SBMFFSino Biopharmaceutical Limited$0.63+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About WXIBF

What is the current price of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) is trading at $4.40 per share.

What is the 52-week range for WuXi Biologics (Cayman)?

Over the past 52 weeks, WuXi Biologics (Cayman) has traded between $2.85 and $5.61.

How much debt does WuXi Biologics (Cayman) have?

As of the most recent reporting period, WuXi Biologics (Cayman) reported total debt of CN¥444.19M.

How much cash does WuXi Biologics (Cayman) have on hand?

WuXi Biologics (Cayman) reported CN¥1.32B in cash and cash equivalents in its most recent financial results.

What is WuXi Biologics (Cayman)’s dividend yield?

WuXi Biologics (Cayman) does not currently have a dividend yield.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Financials at a Glance

WXIBF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About WuXi Biologics (Cayman)

WXIBF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WXIBF

What is the current price of WuXi Biologics (Cayman)?

What is the 52-week range for WuXi Biologics (Cayman)?

How much debt does WuXi Biologics (Cayman) have?

How much cash does WuXi Biologics (Cayman) have on hand?

What is WuXi Biologics (Cayman)’s dividend yield?

Premium Investing Services